131587-34-3

Upstream product

• 3612-20-2 1-phenylmethyl-4-piperidone 
• 1664-61-5 dihydrocinnamamide 

Downstream Products

• 141134-83-0 3,4-dihydro-1-(4-piperidyl)-2(1H)-quinoline hydrochloride 
• 131631-89-5 OPC-21268 
• 131586-57-7 1-{1-[4-(8-Amino-octyloxy)-benzoyl]-piperidin-4-yl}-3,4-dihydro-1H-quinolin-2-one 
• 131584-27-5 1-{1-[4-(6-Aminohexyloxy)benzoyl]-4-piperidinyl}-3,4-dihydrocarbostyril 
• 131633-06-2 Acetic acid 3-[4-(2-oxo-3,4-dihydro-2H-quinolin-1-yl)-piperidine-1-carbonyl]-phenyl ester 
• 131632-30-9 Acetic acid 2-[4-(2-oxo-3,4-dihydro-2H-quinolin-1-yl)-piperidine-1-carbonyl]-phenyl ester 
• 131631-95-3 1-{1-[4-(5-Aminopentyloxy)benzoyl]-4-piperidinyl}-3,4-dihydrocarbostyril 
• 131631-85-1 1-{1-[4-(4-aminobutoxy)benzoyl]-4-piperidinyl}-3,4-dihydrocarbostyril 
• 131631-16-8 4-[4-(2-Oxo-3,4-dihydro-2H-quinolin-1-yl)-piperidine-1-carbonyl]-benzoic acid methyl ester 
• 131631-03-3 1-[1-(4-Acetoxybenzoyl)-4-piperidinyl]-3,4-dihydrocarbostyril 
• 131583-69-2 1-{1-[4-(3-Amino-propoxy)-benzoyl]-piperidin-4-yl}-3,4-dihydro-1H-quinolin-2-one 

Relevant academic research and scientific papers

Orally active, nonpeptide vasopressin V1 antagonists. A novel series of 1-(1-substituted 4-piperidyl)-3,4-dihydro-2(1H)-quinolinone

A series of compounds has been synthesized and demonstrated to be antagonists of V1 receptors both in vitro and in vivo. These compounds are structurally related to the 1-(4-piperidyl)-2(1H)-quinolinones, including OPC-21268, an orally bioavail